Cargando…
Causes and imaging features of false positives and false negatives on (18)F-PET/CT in oncologic imaging
BACKGROUND: 18F-FDG is a glucose analogue that is taken up by a wide range of malignancies. 18F-FDG PET-CT is now firmly established as an accurate method for the staging and restaging of various cancers. However, 18F-FDG also accumulates in normal tissue and other non-malignant conditions, and some...
Autores principales: | Long, Niamh M., Smith, Clare S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259390/ https://www.ncbi.nlm.nih.gov/pubmed/22347986 http://dx.doi.org/10.1007/s13244-010-0062-3 |
Ejemplares similares
-
False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases
por: Chang, Jung Min, et al.
Publicado: (2006) -
Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of (18)F-FDG PET/CT
por: Li, Shaolei, et al.
Publicado: (2013) -
FDG-PET/CT pitfalls in oncological head and neck imaging
por: Purohit, Bela S., et al.
Publicado: (2014) -
False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma
por: Corbin, Haley, et al.
Publicado: (2021) -
False-Positive (18)F-FDG PET/CT Uptake in Unilateral Lactation
por: Yip, Joshua Wei Liang, et al.
Publicado: (2020)